Enliven Therapeutics
ELVN
Insidertransaktionen und Aktienkurs 2024-2026
Alle Insidertrades bei Enliven Therapeutics
| Datum |
Typ |
Insider |
Position |
Ø-Preis |
Volumen |
|
4.8.2026
|
Verkauf |
Derynck, Mika K. |
Aufsichtsrat |
60,2 $ |
9.561.587 $ |
|
17.7.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
52,3 $ |
263.374 $ |
|
17.7.2026
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
52,2 $ |
316.780 $ |
|
6.7.2026
|
Verkauf |
Kunkel, Lori Anne |
Aufsichtsrat |
50,4 $ |
504.903 $ |
|
22.6.2026
|
Verkauf |
Orbimed Advisors LLC |
Zehn-Prozent-Eigentümer |
45,2 $ |
39.014.045 $ |
|
17.6.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
43,8 $ |
219.017 $ |
|
17.6.2026
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
43,8 $ |
263.577 $ |
|
15.6.2026
|
Verkauf |
Orbimed Advisors LLC |
Zehn-Prozent-Eigentümer |
45,0 $ |
12.668.988 $ |
|
5.6.2026
|
Verkauf |
Kunkel, Lori Anne |
Aufsichtsrat |
35,2 $ |
345.351 $ |
|
18.5.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
40,3 $ |
198.972 $ |
|
17.4.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
47,1 $ |
238.351 $ |
|
25.3.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
35,1 $ |
1.404.024 $ |
|
17.3.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
27,8 $ |
138.800 $ |
|
10.3.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
30,2 $ |
305.827 $ |
|
9.3.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
30,0 $ |
896.811 $ |
|
6.3.2026
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
29,6 $ |
295.839 $ |
|
17.2.2026
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
26,2 $ |
32.196 $ |
|
17.2.2026
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
26,2 $ |
1.177.862 $ |
|
6.2.2026
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
29,0 $ |
145.219 $ |
|
20.1.2026
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
26,7 $ |
32.901 $ |
|
20.1.2026
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
26,6 $ |
535.099 $ |
|
9.1.2026
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
25,0 $ |
107.125 $ |
|
9.1.2026
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
27,0 $ |
2.482.578 $ |
|
9.1.2026
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
28,2 $ |
1.351.763 $ |
|
8.1.2026
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
25,0 $ |
241.156 $ |
|
8.1.2026
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
22,5 $ |
993.436 $ |
|
19.12.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
16,8 $ |
84.206 $ |
|
8.12.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
21,3 $ |
140.073 $ |
|
19.11.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
22,7 $ |
279.155 $ |
|
17.11.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
21,8 $ |
272.739 $ |
|
7.11.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
17,6 $ |
116.034 $ |
|
20.10.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
22,1 $ |
276.025 $ |
|
17.10.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
21,3 $ |
266.654 $ |
|
7.10.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
20,1 $ |
133.993 $ |
|
29.9.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
20,4 $ |
66.291 $ |
|
26.9.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
20,3 $ |
81.005 $ |
|
26.9.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,1 $ |
74.228 $ |
|
23.9.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
20,0 $ |
30.045 $ |
|
23.9.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,0 $ |
56.084 $ |
|
19.9.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
19,6 $ |
135.697 $ |
|
19.9.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,2 $ |
20.250 $ |
|
17.9.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
19,1 $ |
95.473 $ |
|
8.9.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
20,2 $ |
134.957 $ |
|
27.8.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
20,6 $ |
67.039 $ |
|
21.8.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
20,0 $ |
150.099 $ |
|
20.8.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,0 $ |
30.343 $ |
|
19.8.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,0 $ |
11.800 $ |
|
19.8.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
19,6 $ |
98.118 $ |
|
18.8.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,0 $ |
208.106 $ |
|
7.8.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
18,6 $ |
121.616 $ |
|
28.7.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
20,9 $ |
66.504 $ |
|
21.7.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
22,6 $ |
278.646 $ |
|
17.7.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
22,6 $ |
281.519 $ |
|
10.7.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
22,7 $ |
22.655 $ |
|
7.7.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
20,2 $ |
131.951 $ |
|
27.6.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
21,3 $ |
67.955 $ |
|
20.6.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
21,4 $ |
267.458 $ |
|
17.6.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
22,4 $ |
277.292 $ |
|
13.6.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
22,6 $ |
67.655 $ |
|
9.6.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
20,7 $ |
135.574 $ |
|
3.6.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,0 $ |
150.352 $ |
|
3.6.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
20,0 $ |
150.220 $ |
|
27.5.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
16,2 $ |
52.593 $ |
|
19.5.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
16,5 $ |
82.453 $ |
|
19.5.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
16,3 $ |
81.534 $ |
|
7.5.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
19,2 $ |
122.579 $ |
|
2.5.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,0 $ |
43.409 $ |
|
2.5.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
20,0 $ |
49.424 $ |
|
1.5.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,1 $ |
107.007 $ |
|
1.5.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
20,1 $ |
100.966 $ |
|
28.4.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
18,9 $ |
60.738 $ |
|
21.4.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
16,4 $ |
80.366 $ |
|
17.4.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
16,4 $ |
82.096 $ |
|
7.4.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
18,5 $ |
120.268 $ |
|
27.3.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
21,3 $ |
69.321 $ |
|
24.3.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
22,5 $ |
22.505 $ |
|
19.3.2025
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
20,6 $ |
257.575 $ |
|
17.3.2025
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
20,8 $ |
260.320 $ |
|
7.3.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
21,4 $ |
142.936 $ |
|
27.2.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
20,4 $ |
66.327 $ |
|
7.2.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
21,9 $ |
146.206 $ |
|
5.2.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
22,5 $ |
22.524 $ |
|
27.1.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
21,6 $ |
70.178 $ |
|
7.1.2025
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
24,4 $ |
685.869 $ |
|
3.1.2025
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
25,0 $ |
25.039 $ |
|
30.12.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
22,5 $ |
20.255 $ |
|
27.12.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
22,2 $ |
74.219 $ |
|
27.11.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
25,1 $ |
130.689 $ |
|
28.10.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
28,8 $ |
178.484 $ |
|
18.10.2024
|
Verkauf |
Collins, Helen Louise |
CHIEF MEDICAL OFFICER |
30,0 $ |
24.482 $ |
|
18.10.2024
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
30,0 $ |
47.104 $ |
|
18.10.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
30,0 $ |
24.422 $ |
|
18.10.2024
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
30,0 $ |
27.723 $ |
|
18.10.2024
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
30,0 $ |
25.413 $ |
|
18.10.2024
|
Verkauf |
Patel, Anish |
CHIEF OPERATING OFFICER |
30,0 $ |
21.483 $ |
|
15.10.2024
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
27,7 $ |
35.143 $ |
|
9.10.2024
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
28,3 $ |
470.405 $ |
|
9.10.2024
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
28,3 $ |
1.066.561 $ |
|
8.10.2024
|
Verkauf |
Ballal, Rahul D. |
Aufsichtsrat |
28,2 $ |
293.557 $ |
|
8.10.2024
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
28,2 $ |
370.929 $ |
|
8.10.2024
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
28,2 $ |
371.024 $ |
|
7.10.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
27,5 $ |
34.935 $ |
|
7.10.2024
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
27,5 $ |
75.075 $ |
|
7.10.2024
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
27,6 $ |
74.727 $ |
|
4.10.2024
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
27,5 $ |
77.704 $ |
|
4.10.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
27,5 $ |
281.079 $ |
|
4.10.2024
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
27,5 $ |
335.792 $ |
|
4.10.2024
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
27,5 $ |
206.937 $ |
|
1.10.2024
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
27,5 $ |
14.264 $ |
|
1.10.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
27,5 $ |
14.347 $ |
|
1.10.2024
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
27,5 $ |
14.485 $ |
|
1.10.2024
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
27,5 $ |
14.512 $ |
|
30.9.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
25,3 $ |
50.668 $ |
|
27.9.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
24,3 $ |
103.161 $ |
|
16.9.2024
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
22,4 $ |
28.458 $ |
|
29.8.2024
|
Verkauf |
Lyssikatos, Joseph P. |
CHIEF SCIENTIFIC OFFICER |
22,8 $ |
269.841 $ |
|
27.8.2024
|
Verkauf |
Hohl, Benjamin |
CHIEF FINANCIAL OFFICER |
22,5 $ |
95.782 $ |
|
26.8.2024
|
Verkauf |
Kintz, Samuel |
PRESIDENT AND CEO |
22,9 $ |
274.718 $ |
|
15.8.2024
|
Verkauf |
Heyman, Richard A. |
Aufsichtsrat |
23,3 $ |
29.527 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)
Kostenlose Updates per Mail
Bestätige noch deine Email-Adresse